Aplanalyst : PKMP - Pharmacokinetic Modeling Program

PKMP - Pharmacokinetic Modeling Program

Pharmacokinetic,Pharmacokinetic Software,PKMP, Pharmacodynamics Software, Pharmacokinetic Modeling Program,Noncompartmental Pharmacokinetic Analysis,Bioequivalency,Urine Pharmacokinetics,Pharmacodymamic Modeling,Clinical Pharmacology,Dissolution,Dissolution Profile Comparison,Dissolution Models,In Vitro-In Vivo Correlation,IVIVC,Deconvolution,Convolution,Pharmacokinetic Simulation,Pharmacokinetic,Pharmacodynamic,IVIVC,DISSOLUTION,SIMULATION,NCA,CA,PD,Levels A, B, C, and Levy Plots,Multivariate statistical distance,Profile Comparisons,Dissolution Models,Noncomparmental PK analysis,Compartmental PK Analysis,Dissolution Data Analysis,In vitro – in vivo Correlation,Plasma PK Analysis,Urine PK Analysis,Superposition Analysis,Bio Eeqvalalce,Anova,Dose proportionality,Sample size calculation,Pharmacokinetics,Oral (1CBM, 2CBM),Intravenous (1CBM, 2CBM, 3CBM),Intravenous infusion (1CBM, 2CBM, 3CBM),Pharmacodynamics,Emax,Sigmoidal Emax,Inhibitory Emax,Sigmoidal inhibitory Emax,Wagner-Nelson Method,Loo-Riegelman Method,Numeric Deconvolution,Level A correlation,Convolution,Pharmacokinetic,Pharmacodynamic,IVIVC,DISSOLUTION,SIMULATION,NCA,CA,PD,Levels A, B, C, and Levy Plots,Multivariate statistical distance,Profile Comparisons,Dissolution Models,Noncomparmental PK analysis,Compartmental PK Analysis,Dissolution Data Analysis,In vitro – in vivo Correlation,Plasma PK Analysis,Urine PK Analysis,Superposition Analysis,Bio Eeqvalalce,Anova,Dose proportionality,Sample size calculation,Pharmacokinetics,Oral (1CBM, 2CBM),Intravenous (1CBM, 2CBM, 3CBM),Intravenous infusion (1CBM, 2CBM, 3CBM),Pharmacodynamics,Emax,Sigmoidal Emax,Inhibitory Emax,Sigmoidal inhibitory Emax,Wagner-Nelson Method,Loo-Riegelman Method,Numeric Deconvolution,Level A correlation,Convolution

APL is pharma software solution and consulting services company supporting pharmaceutical research and development.Our software, pharmacokinetic modeling program (PKMP) will support data analysis in the following key areas of drug development: lead identification/optimization, dose response analysis, bioequivalence analysis of products, in vitro-in vivo correlations for formulations, dissolution data analysis, modeling and predictions.